Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Sarcoma 37Rhabdomyosarcoma 25Sarcoma, Ewing 18Dendritic Cell Sarcoma, Interdigitating 17Lymphoma 13Neuroectodermal Tumors, Primitive, Peripheral 10Lymphoma, Large B-Cell, Diffuse 10Neuroblastoma 8Malignant mesenchymal tumor 8HIV Infections 8Sarcoma, Kaposi 7Osteosarcoma 7Burkitt Lymphoma 7Acquired Immunodeficiency Syndrome 7Desmoplastic Small Round Cell Tumor 6Leukemia 5Wilms Tumor 4Neoplasms 4Lymphoma, Non-Hodgkin 4Central Nervous System Neoplasms 4Brain Neoplasms 4Astrocytoma 4Rhabdomyosarcoma, Embryonal 3Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Liposarcoma 3Gliosarcoma 3Glioblastoma 3Fibrosarcoma 3Bone Neoplasms 3

Interventions

Ifosfamide 5Filgrastim 5Doxorubicin 5Gemcitabine 4Docetaxel 4Radiotherapy 3Proton Therapy 3Carboplatin 3regorafenib 2ivosidenib 2enasidenib 2belinostat 2Sunitinib 2Peripheral Blood Stem Cell Transplantation 2Nivolumab 2Immune Checkpoint Inhibitors 2HhAntag691 2Fluorouracil 2Etoposide 2Epirubicin 2Cyclophosphamide 2Cisplatin 2Chemotherapy, Adjuvant 2Celecoxib 2Bevacizumab 2venetoclax 1toripalimab 1temsirolimus 1tazemetostat 1tanespimycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × Vincristine × Sarcoma × Clear all
NCT00025441 2013-12-04

Combination Chemotherapy in Treating Children With Metastatic Rhabdomyosarcoma or Other Malignant Mesenchymal Tumors

National Cancer Institute (NCI)

Phase 2 Completed
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Fibrosarcoma, Hemangiosarcoma, Liposarcoma, Ovarian Neoplasms, Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral, Desmoplastic Small Round Cell Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡